echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > Xia Lu, First Affiliated Hospital of Xiamen University, et al.: Zinc finger protein 750 promotes colorectal cancer cancer and affects drug treatment response by promoting long-chain non-coding RNACYTOR expression

    Xia Lu, First Affiliated Hospital of Xiamen University, et al.: Zinc finger protein 750 promotes colorectal cancer cancer and affects drug treatment response by promoting long-chain non-coding RNACYTOR expression

    • Last Update: 2022-09-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com



    Contents

    Summary of Chinese:

    Objective:

    To investigate the relevant phenotype and mechanism of zinc finger protein 750 in regulating the expression of long-chain non-coding RNA CYTOR and thus influencing the occurrence and development of colorectal cancer and its potential clinical significance



    Innovation:

    Focus on the pro-cancer mechanism of zinc finger protein 750 in colon adenocarcinoma, and study


    Method:

    At the molecular level, the expression of ZNF750 and CYTOR in colon adenocarcinoma cell lines was analyzed by western blotting, chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-qPCR), transcriptome sequencing (RNA-seq), reverse transcription-quantitative polymerase chain reaction (RT-qPCR).



    Conclusion:

    Zinc finger protein 750 positively regulates CYTOR expression, and zinc finger protein 750-CYTOR promotes malignant phenotype



    Keyword group:

    Zinc finger protein 750; Adenocarcinoma of the colon; Long-chain non-coding RNACYTOR; Chemotherapeutic therapy


    Author:

    Lu XIA, Hexin LIN, Yanming ZHOU, Jiabian LIAN


    This document cites the format:

    Lu XIA, Hexin LIN, Yanming ZHOU, Jiabian LIAN.


    http://doi.


    The essentials of this article are:

    Full-text download address:


    https://jzus.



    About this journal

    Journal of Zhejiang University (English Edition) Series B: Biomedicine and Biotechnology, abbreviated as JZUS-B, a monthly journal
    of biology in english.

    JZUS-B has been included in SCI-E since 2008, with a latest impact factor of 5.
    552, and has been searched
    by MEDLINE/PubMed, PMC, Scopus, BA, BIOSIS Previews and other well-known platforms at home and abroad.

    JZUS-B receives articles covering life sciences, medicine, pharmacy, biochemistry, biotechnology and bioengineering, agronomy, ecology and environment, and zoology
    .

    Article types include Review, Article, Perspective, Viewpoint, Editorial, Correspondence, etc
    .

    The journal has been implementing a strict international peer review mechanism, with an average review cycle of 42 days and an average acceptance time of 53 days
    .

    Articles will be immediately pressed online after acceptance, and are generally officially published within 2 months
    .

    "Content-based, flexible form" is the characteristic of
    this journal.

    JZUS-B welcomes outstanding scholars at home and abroad to submit the latest scientific research achievements, controversial topics, review papers, and organize the publication of hot albums
    to this journal.

    Springer Home Page:

    Submission Address:

     


    Contact us

    Zhejiang University Newspaper English edition is a number of English academic journals collectively, the scope of coverage covers all directions of science, engineering, agriculture and medicine, welcome to submit articles to our journal, you can pay attention to our journal public number zdxbywb for more information
    .

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.